Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 24Lymphoma 13Leukemia 13Lymphoma, Follicular 12Rectal Neoplasms 10Prostatic Neoplasms 10Colonic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Colorectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Congenital Abnormalities 7Ovarian Neoplasms 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myeloid, Acute 6Kidney Neoplasms 6Carcinoma, Ovarian Epithelial 6Burkitt Lymphoma 6Neuroblastoma 5Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Central Nervous System Neoplasms 5Adenocarcinoma of Lung 5

Interventions

pembrolizumab 156Gemcitabine 140Capecitabine 123Paclitaxel 120Fluorouracil 117Oxaliplatin 110Bevacizumab 106Nivolumab 99Leucovorin 97Docetaxel 97Cisplatin 89Radiosurgery 88Irinotecan 87Carboplatin 85Cetuximab 72Cyclophosphamide 71Magnetic Resonance Spectroscopy 68Specimen Handling 60Radiotherapy 60Trastuzumab 59Biopsy 59Ipilimumab 53Drug Therapy 51Everolimus 48Pemetrexed 46Albumin-Bound Paclitaxel 45130-nm albumin-bound paclitaxel 44Doxorubicin 42Fulvestrant 40aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01015560 2018-08-09

S0916, MLN1202 in Treating Patients With Bone Metastases

SWOG Cancer Research Network

Phase 2 Completed
44 enrolled 7 charts
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡